Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- ORMP.TA
- Price
- 7.54
- Stock movement down
- -8.20 (-1.16%)
- Company name
- Exchange
- (TA ,
- Currency
- ILA )
- Sector
- Healthcare >Biotechnology
- Markedsværdi
- 28.71B
- Ent værdi
- -
- Pris/omsætning
- -
- Pris/bog
- -
- Udbytte afkast
- -
- Udbyttevækst
- -
- Vekst år
- -
- FCF-udbetaling
- -
- Efterfølgende P/E
- -
- Fremtidig P/E
- -
- PEG
- -
- EPS-vekst
- -
- 1 års afkast
- 8084.90%
- 3 års afkast
- 189.78%
- 5 års afkast
- -10.12%
- 10 års afkast
- -
Senest opdateret: 2025-09-17
UDBYTTE
ORMP.TA betaler ikke udbytte
VÆRDIANSÆTTELSE
Værdiansættelsesforhold
Loading...
Værdiansættelsesforhold-data
| Efterfølgende P/E | - |
| Pris til OCF | - |
| Pris til FCF | - |
| Pris til EBITDA | - |
| EV i forhold til EBITDA | - |
Værdiansættelse (salg/bogført værdi)
Loading...
Værdiansættelse (salg/bogført værdi)-data
| Pris til omsætning | - |
| Pris til egenkapital | - |
| EV i forhold til salg | - |
ØKONOMI
INFORMATION OM AKTIER
Aktiediagram
Loading...
Aktiekurs-data
| Åbning | 707.30 |
| Daglig høj | 707.30 |
| Daglig lav | 700.00 |
| Daglig volumen | 7K |
| Højeste gennem alle tider | 3365.00 |
| 1 års analytiker estimat | - |
| Beta | - |
| EPS (TTM) | - |
| Udbytte pr. aktie | - |
| Ex-div dato | - |
| Næste dato for resultatpræsentation | 6 Nov 2025 |
Nedsidepotensial
Loading...
Nedsidepotensial-data
| ORMP.TA | S&P500 | |
| Nuværende prisfald fra top notering | -79.19% | -1.06% |
| Højeste prisfald | -99.81% | -56.47% |
| Højeste efterår dato | 29 Jan 2023 | 9 Mar 2009 |
| Gennemsnitlig fald fra toppen | -79.50% | -10.99% |
| Gennemsnitlig tid til nyt højdepunkt | 608 days | 12 days |
| Maks. tid til nyt højdepunkt | 1810 days | 1805 days |
OPLYSNINGER OM VIRKSOMHEDEN
Markedsværdi
28.71B
Markedsværdi kategori
Large-cap
Beskrivelse
Personale
Investor relationer
-
SEC-indsendelser
Adm. direktør
Land
By
Aktietype
-
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRÆSENTATIONER
ArrangementerPræsentationer
Loading...
FORSTÅ FORRETNINGEN
Loading...
NYHEDER OM VIRKSOMHEDEN
Alle nyhederPressemeddelelser
PALO ALTO, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and co...
1. oktober 2025
NEW YORK (AP) — Oramed Pharmaceuticals Inc. ORMP) on Thursday reported net income of $13.3 million in its second quarter. On a per-share basis, the New York-based company said it had profit of 31 cent...
14. august 2025
By M. Marin NASDAQ:ORMP READ THE FULL ORMP RESEARCH REPORT Company maintains substantial liquidity Oramed Pharmaceuticals (NASDAQ:ORMP) had cash of $74.5 million at the end of March 2025, up from $54....
28. juli 2025
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
27. juni 2025
Investing in stocks inevitably means buying into some companies that perform poorly. But the long term shareholders of...
17. maj 2025
NEW YORK (AP) — Oramed Pharmaceuticals Inc. ORMP) on Thursday reported a loss of $7.6 million in its first quarter. On a per-share basis, the New York-based company said it had a loss of 19 cents.
15. maj 2025
Investment comes at a pivotal moment for Alpha Tau, which is experiencing remarkable growth on multiple fronts, with four active U.S. trial approvals, expansion into multiple internal organ applicatio...
28. april 2025
Oramed Pharmaceuticals Inc. ("Oramed" or the "Company"), (Nasdaq: ORMP) (TASE: ORMP), a platform technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection,...
28. april 2025
By M. Marin NASDAQ:ORMP READ THE FULL ORMP RESEARCH REPORT Planning Spin-off / IPO of JV Company Oramed Pharmaceuticals (NASDAQ:ORMP) formed a JV with Hefei Tianhui Biotech (HTIT), OraTech Pharmaceuti...
3. april 2025
As the United States stock market grapples with volatility, driven by concerns about economic health and shifting investor sentiment, opportunities in lesser-known areas like penny stocks are gaining ...
13. marts 2025
Næste side